NCT02469389 Improving Negative Symptoms & Community Engagement in Veterans With Schizophrenia Status COMPLETED Phase NA
NCT02469155 A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment Status COMPLETED Phase PHASE3
NCT02462473 A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass Spectrometry Status TERMINATED Phase PHASE2
NCT02458924 Niacin Skin Flush Response in Patients With Schizophrenia Status COMPLETED Phase PHASE2/PHASE3
NCT02453893 Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia Status UNKNOWN Phase PHASE3
NCT02453217 The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial Status COMPLETED Phase NA
NCT02451670 Reducing Cardiovascular Risk in Adults With Serious Mental Illness Status COMPLETED Phase NA
NCT02451371 Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia Status COMPLETED Phase PHASE1/PHASE2
NCT02435836 A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia Status TERMINATED Phase PHASE3
NCT02435784 The Two-Way Communication Checklist (2-COM) in First Episode Psychosis Patients in Hong Kong Status COMPLETED Phase NA
NCT02435095 Antipsychotic Induced Structural and Functional Brain Changes Status TERMINATED Phase PHASE4
NCT02431702 A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or Schizophreniform Status COMPLETED Phase PHASE3
NCT02426983 Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination Status UNKNOWN Phase PHASE1/PHASE2